Regenova Pharmaceuticals is a biotechnology company that integrates advanced AI with deep immunology expertise to design and develop next‑generation antibody therapeutics. The company focuses on immune therapies for cancers and infectious diseases, aiming to shorten discovery timelines and reduce costs. Regenova partners across multiple stages of the drug development pipeline to accelerate the translation of biologics from idea to clinic.
Subscribe to our newsletter to stay up to date with the latest news.
